Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers

Epilepsy and Behavior

Volumn 5, Issue 6, 2004, Pages 894-902

  Salinsky, M C ^a   Spencer, D C ^a   Oken, B S ^a   Storzbach, D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cognition; EEG; Neurotoxicity; Oxcarbazepine; Phenytoin

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; CANNABIS; IBUPROFEN; NAPROXEN; NARCOTIC AGENT; OXCARBAZEPINE; PARACETAMOL; PHENYTOIN;

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD CHEMISTRY; BLOOD DISEASE; CALCULATION; CLINICAL TRIAL; COGNITION; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELTA RHYTHM; DEPRESSION; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG RESPONSE; DRUG TOLERABILITY; DRUG URINE LEVEL; ELECTROENCEPHALOGRAM; ENERGY; FATIGUE; FEMALE; FREQUENCY MODULATION; HUMAN; HUMAN EXPERIMENT; LONGITUDINAL STUDY; MALE; MEASUREMENT; MOTOR PERFORMANCE; NAUSEA; NEUROTOXICITY; NORMAL HUMAN; PARALLEL DESIGN; PSYCHOLOGIC ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REACTION TIME; REGRESSION ANALYSIS; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THETA RHYTHM; VELOCITY; VOLUNTEER;

ADOLESCENT; ADULT; AFFECT; ANTICONVULSANTS; CARBAMAZEPINE; COGNITION; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHENYTOIN; PSYCHOMOTOR PERFORMANCE; REACTION TIME; REGRESSION ANALYSIS;

EID: 10844278240     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2004.07.011     Document Type: Article

References (45)

1. D. Smith R. Mattson J. Cramer et al. Results of a nationwide Veterans Administration Cooperative study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone Epilepsia 28 Suppl. 3 1987 50-58
2. R.H. Mattson J. Cramer J. Collins A comparison of valproate with carbamazepine for the treatment of partial and secondarily generalized tonic-clonic seizures in adults N. Engl. J. Med. 327 1992 765-771
3. M. Brodie A. Richens A. Yuen et al. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy Lancet 345 1995 476-479
4. M. Dam R. Ekberg Y. Loyning O. Waltimo K. Jacobsen A double blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy Epilepsy Res. 3 1989 70-76
5. P. Bill U. Vigonious H. Pohlmann et al. A double-blind controlled clinical trial of oxcarbazepine vs. phenytoin in adults with previously untreated epilepsy Epilepsy Res. 27 1997 195-204
6. R. Gillham K. Kane L. Bryant-Comstock M. Brodie A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health related quality of life as an outcome measure Seizure 9 2000 375-379
7. A. Marson Z. Kdir J. Hutton D. Chadwick The new antiepileptic drugs: A systematic review of their efficacy and tolerability Epilepsia 38 1997 859-880
8. F. Gilliam Optimizing health outcomes in active epilepsy Neurology 58 Suppl. 5 2002 s9-s20
9. C. Dodrill Effects of antiepileptic drugs on abilities J. Clin. Psychiatry 49 Suppl. 1 1988 31-34
10. R. Gillham N. Williams K. Wiedmann E. Butler M. Brodie Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients J. Neurol. Neurosurg. Psychiatry 51 1988 929-933
11. K. Meador D. Loring E. Moore et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults Neurology 45 1995 1494-1499
12. K. Meador D. Loring M. Allen et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults Neurology 41 1991 1537-1540
13. R. Martin R. Kuzniecky S. Ho et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults Neurology 52 1999 321-327
14. M. Salinsky L. Binder D. Storzbach B. Oken Assessment of CNS effects of antiepileptic drugs using quantitative EEG measures Epilepsia 44 8 2003 1042-1050
15. C. Dodrill Diphenylhydantoin serum levels, toxicity and neuropsychological performance in patients with epilepsy Epilepsia 16 1975 593-600
16. C. Dodrill A. Troupin Neuropsychological effects of carbamazepine and phenytoin: A reanalysis Neurology 41 1991 141-143
17. M. Salinsky D. Storzbach L. Binder C. Arons C. Dodrill Effects of gabapentin and carbamazepine on the EEG, alertness, and cognition in healthy volunteers Epilepsia 43 2002 482-490
18. S. Schachter B. Vazquez R. Fisher et al. Oxcarbazepine: Double-blind, randomized, placebo-controlled, monotherapy trial for partial seizures Neurology 52 1999 732-737
19. K. Reinikainen T. Keranan T. Halonen H. Komulainen P. Riekkinen Comparison of oxcarbazepine and carbamazepine: A double blind study Epilepsy Res. 1 1987 284-289
20. A. Baruzzi F. Albani R. Riva Oxcarbazepine: Pharmacokinetic interactions and their clinical relevance Epilepsia 35 Suppl. 3 1994 s14-s9
21. R. Reitan D. Wolfram The Halstead-Reitan Neuropsychological Test Battery 1985 Neuropsychology Press Tucson
22. D. Wechsler WAIS-R Manual 1981 Psychological New York
23. C. Dodrill A neuropsychological test battery for epilepsy Epilepsia 19 1978 611-623
24. H. Bushke P. Fuld Evaluating storage, retention and retrieval in disordered memory and learning Neurology 24 1974 1019-1025
25. Larrabee G, Trahan D, Levin H. Normative data for the verbal selective reminding test. In: Proceedings of the 14th Meeting of the International Neuropsychological Society, 1986
26. C. Dodrill J. Arnett K. Somerville N. Sussman Effects of differing dosages of vigabatrin on cognitive abilities and quality of life in epilepsy Epilepsia 36 1995 164-173
27. E. Miller P. Satz B. Visscher Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men Neurology 41 1991 1608-1616
28. C. Dodrill When is computer assisted testing appropriate? In: W. Dodson M. Kinsbourne B. Hiltbrunner, editors. The assessment of cognitive function in epilepsy 1991 Demos New York 23-34
29. D. McNair M. Lorr L. Dropplemann Profile of mood states 1981 Educational and Industrial Testing Service San Diego
30. M. Salinsky B. Oken L. Binder Assessment of drowsiness in epilepsy patients receiving chronic antiepileptic drug therapy Epilepsia 37 1996 181-187
31. M. Salinsky B. Oken L. Morehead Test-retest reliability in EEG frequency analysis Electroncephalogr. Clin. Neurophysiol. 79 1991 382-392
32. M. Salinsky B. Oken L. Morehead Intraindividual longitudinal analysis of antiepileptic drug effects on EEG background rhythms Electroencephalogr. Clin. Neurophysiol. 90 1994 186-193
33. V. Valley R. Broughton The physiological (EEG) nature of drowsiness and its relation to performance deficits in narcoleptics Electroencephalogr. Clin. Neurophysiol. 55 1983 243-251
34. M. Salinsky L. Binder C. Dodrill D. Storzbach Test-retest bias, reliability, and regression equations for neuropsychological measures repeated over a 12-16 week interval J. Int. Neuropsychol. Soc. 7 2001 597-605
35. B. Hermann M. Seidenberg J. Schoenfeld Empirical techniques for determining the reliability, magnitude, and pattern of neuropsychological change after epilepsy surgery Epilepsia 37 1996 942-950
36. S. Sawrie G. Chelune R. Naugle H. Luders Empirical methods for assessing meaningful neuropsychological change following epilepsy surgery J. Int. Neuropsychol. Soc. 2 1996 556-564
37. G. Vas J. Cracco Diffuse encephalopathies In: D. Daly T. Pedley, editors. Current practice in clinical electroencephalography 1990 Demos New York 371-400
38. E. Niedemeyer Metabolic central nervous system disorders In: E. Niedemeyer F. Lopes Da Silva, editors. Electroencephalography: Basic principles, clinical applications, and related fields 1999 Lippincott, Williams Wilkins Philadelphia 369-382
39. B. Jansen Quantitative EEG analysis of renal disease In: F. Lopes Da Silva W. Storm Van Leeuwen A. Remond, editors Clinical applications of computer analysis of EEG and other neurophysiological signals 1986 Elsevier Amsterdam 239-257
40. E. Rosemann Dilantin toxicity: A clinical and electroencephalographic study Neurology 11 1961 912-921
41. B. Jensen V. Grynerup Studies on the metabolism of phenytoin Epilepsia 7 1966 238-245
42. G.K. Herkes T.D. Lagerlund F.W. Sharbrough M.J. Eadie Effects of antiepileptic drug treatment on the background frequency of EEGs in epileptic patients J. Clin. Neurophysiol 10 1993 210-216
43. J. Frost R. Hrachovy D. Glaze G. Rettig Alpha rhythm slowing during initiation of carbamazepine therapy: Implications for future cognitive performance J. Clin. Neurophys. 12 1995 57-63
44. M. Aikia R. Kalviainen J. Sivenius T. Halonen P.J. Riekkinen Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: One year follow-up Epilepsy Res. 11 1992 199-203
45. C. Dodrill N. Temkin Motor speed is a contaminating factor in evaluating the cognitive effects of phenytoin Epilepsia 30 1989 453-457